Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Traditional and complementary medicine may help with skin conditions, but more high-quality research is needed.

Men need higher doses of botox than women and a different approach for facial aesthetics due to their unique facial features and muscle mass.

Oral dutasteride works better for hair loss, but has more sexual side effects; intralesional dutasteride is a possible alternative.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Dutasteride is more effective than finasteride for hair loss treatment.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Microneedles are being used and tested for various medical and cosmetic treatments.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Platelet-Rich Plasma therapy helps increase hair density and regrowth for some types of hair loss.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

The combination treatment showed a higher response rate but no significant survival benefits.

Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.

Dutasteride helps reduce male pattern hair loss, but may cause side effects like altered libido and erectile dysfunction.